Tylenol Safety Claims Reignite After 2017 Pregnancy Warning Tweet Resurfaces

The Trump administration recently reignited controversy by warning pregnant women against using Tylenol, claiming a link between its active ingredient acetaminophen and autism, despite no new scientific evidence supporting this. This claim was amplified when the White House highlighted a 2017 Tylenol tweet advising against use during pregnancy, which the company later clarified was an incomplete response to a customer and reaffirmed that acetaminophen remains the safest pain reliever for pregnant women when used as directed. Medical experts and regulatory bodies, including Britain's MHRA and the World Health Organization, have stated there is no credible evidence linking acetaminophen use in pregnancy to autism, emphasizing that medications should be used cautiously and under medical advice. The White House reposted the old Tylenol tweet alongside a photo of President Trump, framing it as validation of their stance amidst criticism from doctors and media outlets. Meanwhile, Tylenol and health professionals urge consultation with doctors before taking any medication during pregnancy, highlighting that cautionary warnings are standard due to ethical considerations in testing on pregnant women. The debate has also drawn criticism of media coverage, which some argue has selectively reported on Tylenol risks despite longstanding warnings about its cautious use in pregnancy.